Paracrine regulation of growth hormone secretion by estrogen in women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3771-3776

  Birzniece, Vita ^a   Sata, Akira ^a   Sutanto, Surya ^a   Ho, Ken K Y ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTRADIOL VALERATE; ESTROGEN; GROWTH HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TAMOXIFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE RELEASE; HUMAN; PARACRINE SIGNALING; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 77955374469     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0476     Document Type: Article

References (31)

1. Kamegai J, Tamura H, Shimizu T, Ishii S, Tatsuguchi A, Sugihara H, Oikawa S, Kineman RD 2004 The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 145:3731-3738 (Pubitemid 39037559)
2. Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley Jr WF, Hayes FJ 2008 Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 93:784-791 (Pubitemid 351398554)
3. Weissberger AJ, Ho KK 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 76:1407-1412
4. Veldhuis JD, Metzger DL, Martha Jr PM, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM 1997 Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414-3420 (Pubitemid 27419097)
5. Weissberger AJ, Ho KK, Lazarus L 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381 (Pubitemid 21921702)
6. Gibney J, Johannsson G, Leung KC, Ho KK 2005 Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women. J Clin Endocrinol Metab 90:3897-3903 (Pubitemid 41058148)
7. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR 1996 Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81:2848-2853 (Pubitemid 26323876)
8. Sonnet E, Lacut K, Roudaut N, Mottier D, Kerlan V, Oger E 2007 Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study. Clin Endocrinol (Oxf) 66:626-631 (Pubitemid 46699527)
9. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK 2003 Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100:1016-1021 (Pubitemid 36183947)
10. Chapman IM, Hartman ML, Pieper KS, Skiles EH, Pezzoli SS, Hintz RL, Thorner MO 1998 Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J Clin Endocrinol Metab 83:2836-2842
11. Riggs BL, Hartmann LC 2003 Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 348:618-629 (Pubitemid 36210865)
12. Löfgren L, Wallberg B, Wilking N, Fornander T, Rutqvist LE, Carlström K, von Schoultz B, von Schoultz E 2004 Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. Med Oncol 21:309-318 (Pubitemid 40065482)
13. De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D 2000 Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. Clin Endocrinol (Oxf) 52:681-685 (Pubitemid 30409259)
14. Mandalà M, Moro C, Ferretti G, Calabro MG, Nolè F, Rocca A, Munzone E, Castro A, Curigliano G 2001 Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients. Anticancer Res 21:585-588 (Pubitemid 32267576)
15. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK 1993 Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in postmenopausal women. Clin Endocrinol (Oxf) 39:561-567 (Pubitemid 23323955)
16. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK 2001 Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 281:E1191-E1196 (Pubitemid 34001193)
17. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK 2005 Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271 (Pubitemid 41076627)
18. Corsello SM, Rota CA, Putignano P, Della Casa S, Barnabei A, Migneco MG, Vangeli V, Barini A, Mandalà M, Barone C, Barbarino A 1998 Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer. Eur J Endocrinol 139:309-313 (Pubitemid 28430543)
19. Veldhuis JD, Mielke KL, Cosma M, Soares-Welch C, Paulo R, Miles JM, Bowers CY 2009 Aromatase and 5α-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. J Clin Endocrinol Metab 94:973-981
20. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225 (Pubitemid 19140325)
21. Burt MG, Gibney J, Hoffman DM, Umpleby AM, Ho KK 2008 Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults. Growth Horm IGF Res 18:55-64 (Pubitemid 351228807)
22. Komolov IS, Perez-Arce JA, Fedotov VP 1980 The effects of estradiol on prolactin and growth hormone secretion in cultured pituitary cells from intact and ovariectomized rats. Endokrinologie 75:278-284
23. Simard J, Hubert JF, Hosseinzadeh T, Labrie F 1986 Stimulation of growth hormone release and synthesis by estrogens in rat anterior pituitary cells in culture. Endocrinology 119:2004-2011 (Pubitemid 17171377)
24. Hassan HA, Enright WJ, Tucker HA, Merkel RA 2001 Estrogen and androgen elicit growth hormone release via dissimilar patterns of hypothalamic neuropeptide secretion. Steroids 66:71-80
25. Cosma M, Bailey J, Miles JM, Bowers CY, Veldhuis JD 2008 Pituitary and/or peripheral estrogen-receptor α regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women. J Clin Endocrinol Metab 93:951-958 (Pubitemid 351398579)
26. Shimizu T, Kamegai J, Tamura H, Ishii S, Sugihara H, Oikawa S 2005 The estrogen receptor (ER) α, but not ER β, gene is expressed in hypothalamic growth hormone-releasing hormone neurons of the adult female rat. Neurosci Res 52:121-125 (Pubitemid 40461878)
27. O'Carroll AM, Krempels K 1995 Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 136:5224-5227
28. Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J 1998 Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 139:2272-2277 (Pubitemid 28513747)
29. Kimura N, Tomizawa S, Arai KN, Kimura N 1998 Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 139:1573-1580 (Pubitemid 28513811)
30. Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen C 2004 Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145:604-612 (Pubitemid 38183802)
31. Rochira V, Zirilli L, Maffei L, Premrou V, Aranda C, Baldi M, Ghigo E, Aimaretti G, Carani C, Lanfranco F 2010 Tall stature without growth hormone: four male patients with aromatase deficiency. J Clin Endocrinol Metab 95:1626-1633